This antibody has two distinct antigen-targeting sites—one for the CD3 antigen on T-cells and another for the EpCAM on tumor cells—and also binds to accessory cell FcγR via its preserved Fc region (9). The gene discussed is EPCAM; the disease is neoplasm.